Kevin Valentine, BCBA | |
231 Sycamore Dr, Wofford Heights, CA 93285-9799 | |
(661) 440-1739 | |
Not Available |
Full Name | Kevin Valentine |
---|---|
Gender | Male |
Speciality | Behavior Analyst |
Location | 231 Sycamore Dr, Wofford Heights, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942782628 | NPI | - | NPPES |
14600522 | Other | CAQH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | (* (Not Available)) | Secondary |
103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kevin Valentine, BCBA 231 Sycamore Dr, Wofford Heights, CA 93285-9799 Ph: (661) 440-1739 | Kevin Valentine, BCBA 231 Sycamore Dr, Wofford Heights, CA 93285-9799 Ph: (661) 440-1739 |
News Archive
Medical science liaisons are increasingly forming relationships with key opinion leaders who serve on reimbursement committees, according to a study by Cutting Edge Information.
Encision Inc. – A California jury awarded $2.2 million to a patient in a personal injury, product liability, defective laparoscopic device case against a competing medical device company; as reported in the Daily Journal.
The University of North Carolina at Chapel Hill received two separate grants from the U.S. Food and Drug Administration and the National Institutes of Health today as part of an on-going interagency partnership. UNC will house two of 14 Tobacco Centers of Regulatory Science, which are receiving a total of up to $53 million for tobacco-related research in fiscal year 2013.
Amgen, the world's largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (MN) today announced an agreement under which Amgen will acquire 95.6 percent of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at US $700 million.
› Verified 4 days ago